Your browser doesn't support javascript.
loading
The novel application and effect of an ultraviolet light decontamination strategy on the healthcare acquisition of carbapenem-resistant Enterobacterales in a hospital setting.
Lowman, W; Etheredge, H R; Gaylard, P; Fabian, J.
Afiliación
  • Lowman W; Wits Donald Gordon Medical Centre, University of the Witwatersrand, Parktown, South Africa; Clinical Microbiology & Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: warren.lowman@wits.ac.za.
  • Etheredge HR; Wits Donald Gordon Medical Centre, University of the Witwatersrand, Parktown, South Africa; Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Gaylard P; Data Management and Statistical Analysis, University of the Witwatersrand, Johannesburg, South Africa.
  • Fabian J; Wits Donald Gordon Medical Centre, University of the Witwatersrand, Parktown, South Africa; Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
J Hosp Infect ; 121: 57-64, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34915050
ABSTRACT

BACKGROUND:

The role of the hospital environment as contributory to healthcare acquisition of multidrug-resistant organisms (MDROs) is increasingly recognized. Ultraviolet light decontamination can minimize the environmental bioburden, thereby potentially reducing healthcare acquisition. This effect has been demonstrated for typical environmental MDROs, e.g. meticillin-resistant Staphylococcus aureus, vancomycin-resistant entero-cocci, and Clostridioides difficile; however, its role in reducing carbapenem-resistant Enterobacterales (CRE) incidence rates is unclear.

AIM:

To evaluate the impact of continuous ultraviolet light (C-UV) on healthcare acquisition rates of CRE.

METHODS:

A 26-month pragmatic, prospective interventional study with addition of C-UV decontamination to standard cleaning was conducted in units at high risk for CRE acquisition. Introduction of C-UV followed a 12 month baseline period, with a two-month wash-in period. Implementation included terminal decontamination at discharge and a novel in-use protocol, whereby rooms occupied for ≥48 h were decontaminated during the course of the patients' in-hospital stay. Incidence density rates of CRE during the intervention period were compared to the baseline period using interrupted time series regression. Rates were adjusted for ward/admission prevalence and analysed according to C-UV protocol.

FINDINGS:

The in-use C-UV protocol demonstrated a significant negative association with the incidence density rate of CRE when adjusting for CRE admission rate (P = 0.0069). CRE incidence density rates decreased significantly during the intervention period (P = 0.042). Non-intervention units demonstrated no change in incidence density rates when adjusting for ward and/or admission prevalence.

CONCLUSION:

C-UV decontamination can potentially reduce healthcare acquisition of CRE when implemented with an in-use protocol.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infección Hospitalaria / Staphylococcus aureus Resistente a Meticilina Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Hosp Infect Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infección Hospitalaria / Staphylococcus aureus Resistente a Meticilina Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Hosp Infect Año: 2022 Tipo del documento: Article